Literature DB >> 23969921

Extranodal nasal NK/T-cell lymphoma: a rare oral presentation and FASN, CD44 and GLUT-1 expression.

Hélder Antônio Rebelo Pontes1, Flávia Sirotheau Corrêa Pontes, Brunno Santos de Freitas Silva, Felipe Paiva Fonseca, Bruno Augusto Benevenuto de Andrade, Victor Hugo Toral Rizo, Mário José Romañach, Jorge Esquiche León, Oslei Paes de Almeida.   

Abstract

Extranodal natural killer (NK)/T-cell lymphoma is an aggressive malignant tumor with distinctive clinicopathological features, characterized by vascular invasion and destruction, prominent necrosis, cytotoxic lymphocyte phenotype and a strong association with Epstein-Barr virus. Here is reported an extranodal nasal NK/T-cell lymphoma case, involving the maxillary sinus, floor of the orbit, and interestingly extending to the oral cavity through the alveolar bone and buccal mucosa, preserving the palate, leading to a primary misdiagnosis of aggressive periodontal disease. Moreover, this work investigated for the first time the immunohistochemical expression of fatty acid synthase (FASN) and glucose transporter 1 (GLUT-1) proteins in this neoplasia. FASN showed strong cytoplasmatic expression in the neoplastic cells, whereas GLUT-1 and CD44 were negative. These findings suggest that the expression of FASN and the loss of CD44 might be involved in the pathogenesis of the extranodal nasal NK/T-cell lymphoma, and that GLUT-1 may not participate in the survival adaptation of the tumor cells to the hypoxic environment. Further studies with larger series are required to confirm these initial results.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23969921     DOI: 10.1590/0103-6440201302202

Source DB:  PubMed          Journal:  Braz Dent J        ISSN: 0103-6440


  3 in total

1.  T-cell lymphoma of the oral cavity: case report.

Authors:  Kanika Rana; Vineet Narula; Eishaan K Bhargava; Ravi Shankar; Nidhi Mahajan
Journal:  J Clin Diagn Res       Date:  2015-03-01

2.  Structure guided design and synthesis of furyl thiazolidinedione derivatives as inhibitors of GLUT 1 and GLUT 4, and evaluation of their anti-leukemic potential.

Authors:  Kalpana Tilekar; Neha Upadhyay; Jessica D Hess; Lucasantiago Henze Macias; Piotr Mrowka; Renato J Aguilera; Franz-Josef Meyer-Almes; Cristina V Iancu; Jun-Yong Choe; C S Ramaa
Journal:  Eur J Med Chem       Date:  2020-07-02       Impact factor: 6.514

3.  Permuted 2,4-thiazolidinedione (TZD) analogs as GLUT inhibitors and their in-vitro evaluation in leukemic cells.

Authors:  Kalpana Tilekar; Neha Upadhyay; Markus Schweipert; Jessica D Hess; Lucasantiago Henze Macias; Piotr Mrowka; Franz-Josef Meyer-Almes; Renato J Aguilera; Cristina V Iancu; Jun-Yong Choe; C S Ramaa
Journal:  Eur J Pharm Sci       Date:  2020-08-12       Impact factor: 5.112

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.